Machteld Sillen

5PUBLICATIONS
5CO-AUTHORS
Tumour immunologyToxicology (incl. clinical toxicology)Proteins and peptidesClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 30, 2021
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review.

Machteld Sillen, Paul J Declerck

|Apr 03, 2021
A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?

Machteld Sillen, Paul J Declerck

|Feb 05, 2021
Structural Insight into the Two-Step Mechanism of PAI-1 Inhibition by Small Molecule TM5484.

Machteld Sillen, Toshio Miyata, Douglas E Vaughan

|Aug 23, 2020
Structural Insights into the Mechanism of a Nanobody That Stabilizes PAI-1 and Modulates Its Activity.

Machteld Sillen, Stephen D Weeks, Sergei V Strelkov

|Dec 21, 2019
Molecular mechanism of two nanobodies that inhibit PAI-1 activity reveals a modulation at distinct stages of the PAI-1/plasminogen activator interaction.

Machteld Sillen, Stephen D Weeks, Xiaohua Zhou

Pageof 1